During a retroactive review of past complaints for potential adverse events, conducted as a capa in response to a recent fda inspection, a reportable adverse event was discovered.A (b)(6) female patient contacted zoll customer support to report a bright red rash on her back.The patient is concerned that the rash may be a bacterial infection.The patient contacted zoll customer support on(b)(6) 2009 inquiring about delivery of her "hypoallergenic" therapy pads.Support told the patient that there is only one type of therapy pad available.Patient f/u on (b)(6) 2009 reporting that she is five months pregnant, and her physician had her temporarily remove the lifevest due to the allergic reaction until the baby is born.There was no additional f/u on the alleged bacterial infection or the allergic reaction.
|